Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide ...

Retrieved on: 2024-03-20 12:14:53

Tags for this article:

Click the tags to see associated articles and topics

Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide .... View article details on hiswai:

Excerpt

JERUSALEM, March 20, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally ...

Article found on: www.globenewswire.com